درباره این اپیزود
Dr. Andrew Holman, MD is Co-Founder & Chief Executive Officer of Inmedix ( https://inmedix.com/ ), a medical diagnostics company pioneering the field of stress biology through its FDA-cleared CloudHRV® platform. Inmedix brings cloud-based clinical diagnostics and immuno-autonomics to medicine to improve outcomes in autoimmune diseases and beyond.
Dr. Holman is the founding rheumatologist at Pacific Rheumatology Associates Inc PS, Director of Research at Pacific Rheumatology Research Inc., a former President of the Northwest Rheumatism Society (2005) and a Clinical Associate Professor of Medicine at the University of Washington.
Dr. Holman has 25 year clinical (and 19 year rheumatology) research career experience with 16 lead author published papers, and 25 lead author published abstracts. For Inmedix, he has designed, completed and published 15 clinical studies, including FDA negotiations, involving nearly 1500 patients.
Dr. Holman's research highlights include, but are not limited to, studying the use of dopamine agonists as a treatment of fibromyalgia, exploring the impact of hypermobility syndromes, evaluating innovative autonomic nervous system (ANS) analysis with 5-min heart rate variability (HRV) in patients with rheumatoid arthritis and other autoimmune diseases, and broadening understanding of pain in patients with PC3 (positional cervical cord compression) using dynamic flexion-extension, cervical magnetic resonance imaging (dMRI).
Dr. Holman has his Doctor of Medicine (M.D.), Medicine from University of Missouri-Columbia and did his Rheumatology Fellowship at the University of Washington - School of Medicine.
#AndrewHolman #Inmedix #CloudHRV #ClinicalDiagnostics #ImmunoAutonomics #AutoimmuneDiseases #StressBiology #Rheumatology #Fibromyalgia #RheumatoidArthritis #HeartRateVariability #HRV #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast
